Zsὁfia Iglὁi

1.0k total citations
18 papers, 544 citations indexed

About

Zsὁfia Iglὁi is a scholar working on Infectious Diseases, Hepatology and Biomedical Engineering. According to data from OpenAlex, Zsὁfia Iglὁi has authored 18 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 4 papers in Hepatology and 4 papers in Biomedical Engineering. Recurrent topics in Zsὁfia Iglὁi's work include SARS-CoV-2 and COVID-19 Research (8 papers), SARS-CoV-2 detection and testing (8 papers) and Biosensors and Analytical Detection (4 papers). Zsὁfia Iglὁi is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (8 papers), SARS-CoV-2 detection and testing (8 papers) and Biosensors and Analytical Detection (4 papers). Zsὁfia Iglὁi collaborates with scholars based in Netherlands, United Kingdom and Finland. Zsὁfia Iglὁi's co-authors include Marion Koopmans, Corine H. GeurtsvanKessel, Richard Molenkamp, Annemiek A. van der Eijk, Jeroen J. A. van Kampen, Bart Rijnders, Susanne Bogers, Bart L. Haagmans, Janette Rahamat–Langendoen and Lonneke Leijten and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

In The Last Decade

Zsὁfia Iglὁi

18 papers receiving 541 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zsὁfia Iglὁi Netherlands 11 421 133 129 60 35 18 544
Ute Eberle Germany 9 280 0.7× 132 1.0× 122 0.9× 73 1.2× 7 0.2× 16 396
Krishnamurthy Konduru United States 11 234 0.6× 66 0.5× 106 0.8× 86 1.4× 89 2.5× 20 427
Shangen Zheng China 9 488 1.2× 165 1.2× 163 1.3× 41 0.7× 3 0.1× 28 657
Thiruni Adikari Sri Lanka 9 271 0.6× 68 0.5× 119 0.9× 59 1.0× 5 0.1× 15 463
Janine Michel Germany 12 195 0.5× 47 0.4× 118 0.9× 93 1.6× 4 0.1× 38 406
Su Hui Catherine Teo Singapore 6 448 1.1× 44 0.3× 95 0.7× 72 1.2× 3 0.1× 8 591
Bin Ju China 13 316 0.8× 26 0.2× 137 1.1× 69 1.1× 34 1.0× 58 568
Aurélia Kwasiborski France 8 307 0.7× 195 1.5× 182 1.4× 58 1.0× 10 0.3× 15 493
Chutikarn Chaimayo Thailand 6 200 0.5× 91 0.7× 98 0.8× 105 1.8× 7 0.2× 11 356
Brett Eaton United States 8 414 1.0× 16 0.1× 203 1.6× 161 2.7× 5 0.1× 14 665

Countries citing papers authored by Zsὁfia Iglὁi

Since Specialization
Citations

This map shows the geographic impact of Zsὁfia Iglὁi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zsὁfia Iglὁi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zsὁfia Iglὁi more than expected).

Fields of papers citing papers by Zsὁfia Iglὁi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zsὁfia Iglὁi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zsὁfia Iglὁi. The network helps show where Zsὁfia Iglὁi may publish in the future.

Co-authorship network of co-authors of Zsὁfia Iglὁi

This figure shows the co-authorship network connecting the top 25 collaborators of Zsὁfia Iglὁi. A scholar is included among the top collaborators of Zsὁfia Iglὁi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zsὁfia Iglὁi. Zsὁfia Iglὁi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Iglὁi, Zsὁfia, Laura Pezzı, Rémi N. Charrel, & Marion Koopmans. (2024). Detection of yellow fever virus genome in urine following natural infection or vaccination: review of current knowledge 1985–2023. Journal of Clinical Virology. 175. 105740–105740. 1 indexed citations
2.
Schaeffer, Justine, C Hammer, Iro Evlampidou, et al.. (2023). Field Epidemiology and Public Health Microbiology training: capturing the alumni perspectives of the training’s impact. Eurosurveillance. 28(36). 2 indexed citations
3.
Beek, Janko van, Zsὁfia Iglὁi, Ewout Fanoy, et al.. (2022). From more testing to smart testing:data-guided SARS-CoV-2 testing choices, the Netherlands, May to September 2020. EUR Research Repository (Erasmus University Rotterdam). 7 indexed citations
4.
Schuit, Ewoud, Roderick P Venekamp, Irene Veldhuijzen, et al.. (2022). Head-to-head comparison of the accuracy of saliva and nasal rapid antigen SARS-CoV-2 self-testing: cross-sectional study. BMC Medicine. 20(1). 406–406. 14 indexed citations
5.
Venekamp, Roderick P, Irene Veldhuijzen, Karel G.M. Moons, et al.. (2022). Detection of SARS-CoV-2 infection in the general population by three prevailing rapid antigen tests: cross-sectional diagnostic accuracy study. BMC Medicine. 20(1). 97–97. 9 indexed citations
6.
7.
Iglὁi, Zsὁfia, Ewout Fanoy, Janko van Beek, et al.. (2022). Community-based SARS-CoV-2 testing in low-income neighbourhoods in Rotterdam: Results from a pilot study. Journal of Global Health. 12. 5042–5042. 4 indexed citations
8.
Iglὁi, Zsὁfia, Jans Velzing, R. C. Huisman, et al.. (2021). Clinical evaluation of the SD Biosensor SARS-CoV-2 saliva antigen rapid test with symptomatic and asymptomatic, non-hospitalized patients. PLoS ONE. 16(12). e0260894–e0260894. 15 indexed citations
9.
Friesema, Ingrid, Sjoerd Kuiling, Zsὁfia Iglὁi, & Eelco Franz. (2021). Optimization of Notification Criteria for Shiga Toxin–Producing Escherichia coli Surveillance, the Netherlands. Emerging infectious diseases. 27(1). 258–261. 3 indexed citations
10.
Iglὁi, Zsὁfia, Jans Velzing, Janko van Beek, et al.. (2021). Clinical Evaluation of Roche SD Biosensor Rapid Antigen Test for SARS-CoV-2 in Municipal Health Service Testing Site, the Netherlands. Emerging infectious diseases. 27(5). 1323–1329. 63 indexed citations
11.
GeurtsvanKessel, Corine H., Nisreen M.A. Okba, Zsὁfia Iglὁi, et al.. (2020). An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment. Nature Communications. 11(1). 3436–3436. 231 indexed citations
12.
Iglὁi, Zsὁfia, et al.. (2020). Comparison of commercial realtime reverse transcription PCR assays for the detection of SARS-CoV-2. Journal of Clinical Virology. 129. 104510–104510. 61 indexed citations
13.
Iglὁi, Zsὁfia, Lapo Mughini‐Gras, Laura Nic Lochlainn, et al.. (2018). Long-term sequelae of sporadic cryptosporidiosis: a follow-up study. European Journal of Clinical Microbiology & Infectious Diseases. 37(7). 1377–1384. 17 indexed citations
14.
Iglὁi, Zsὁfia, et al.. (2015). Requirement for Chloride Channel Function during the Hepatitis C Virus Life Cycle. Journal of Virology. 89(7). 4023–4029. 17 indexed citations
15.
Iglὁi, Zsὁfia, Arūnas Kazlauskas, Kalle Saksela, et al.. (2015). Hepatitis C virus NS5A protein blocks epidermal growth factor receptor degradation via a proline motif- dependent interaction. Journal of General Virology. 96(8). 2133–2144. 17 indexed citations
16.
Jardim, Ana Carolina Gomes, Zsὁfia Iglὁi, Jacqueline Farinha Shimizu, et al.. (2014). Natural compounds isolated from Brazilian plants are potent inhibitors of hepatitis C virus replication in vitro. Antiviral Research. 115. 39–47. 26 indexed citations
17.
Amako, Yutaka, Zsὁfia Iglὁi, Jamel Mankouri, et al.. (2013). Hepatitis C Virus NS5A Inhibits Mixed Lineage Kinase 3 to Block Apoptosis. Journal of Biological Chemistry. 288(34). 24753–24763. 25 indexed citations
18.
Iglὁi, Zsὁfia, et al.. (2008). Expression, purification and activities of the entire family of intact membrane sensor kinases fromEnterococcus faecalis. Molecular Membrane Biology. 25(6-7). 449–473. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ute Eberle Breakdown of academic impact, for papers by Krishnamurthy Konduru Breakdown of academic impact, for papers by Shangen Zheng Breakdown of academic impact, for papers by Thiruni Adikari Breakdown of academic impact, for papers by Janine Michel Breakdown of academic impact, for papers by Su Hui Catherine Teo Breakdown of academic impact, for papers by Bin Ju Breakdown of academic impact, for papers by Aurélia Kwasiborski Breakdown of academic impact, for papers by Chutikarn Chaimayo Breakdown of academic impact, for papers by Brett Eaton
Rankless by CCL
2026